Keywords: flat, 2nd-qtr, sales/eps, schering-plough, despite, strong, growth
Flat 2nd-qtr sales/EPS at Schering-Plough
Article | 25 July 2001
Despite strong growth for some of its newer products, Schering-Ploughreported flat first-quarter 2001 sales at $2.6 billion (up 3% excluding currency factors) and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
